IN2013MU02584A - - Google Patents

Info

Publication number
IN2013MU02584A
IN2013MU02584A IN2584MU2013A IN2013MU02584A IN 2013MU02584 A IN2013MU02584 A IN 2013MU02584A IN 2584MU2013 A IN2584MU2013 A IN 2584MU2013A IN 2013MU02584 A IN2013MU02584 A IN 2013MU02584A
Authority
IN
India
Prior art keywords
moisture
sensitive
apis
api
present
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Jain Girish
Venkataramana Naidu
Gupta Saurabh
Agarwal Amar
Srikanth Pattipati
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN2584MU2013 priority Critical patent/IN2013MU02584A/en
Publication of IN2013MU02584A publication Critical patent/IN2013MU02584A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
IN2584MU2013 2013-08-05 2013-08-05 IN2013MU02584A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2584MU2013 IN2013MU02584A (fr) 2013-08-05 2013-08-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2584MU2013 IN2013MU02584A (fr) 2013-08-05 2013-08-05

Publications (1)

Publication Number Publication Date
IN2013MU02584A true IN2013MU02584A (fr) 2015-06-12

Family

ID=54199328

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2584MU2013 IN2013MU02584A (fr) 2013-08-05 2013-08-05

Country Status (1)

Country Link
IN (1) IN2013MU02584A (fr)

Similar Documents

Publication Publication Date Title
PH12020500336A1 (en) FORMULATION FOR ANTI-a4á7 ANTIBODY
BR112017022604A2 (pt) composto, composição farmacêutica, uso de um composto e de uma combinação, e, combinação
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2016001023A (es) Formulaciones que contienen dapagliflozina amorfa.
PE20150199A1 (es) Composiciones farmaceuticas y tratamiento de mastitis
IN2015DN01165A (fr)
PH12017501133A1 (en) Pyrazolopyridinamines
TN2015000371A1 (en) Substituted imidazopyridazines
EA201491937A1 (ru) Инъецируемая композиция
MX340985B (es) Compuestos de n-heteroarilo.
WO2013134534A3 (fr) Formes à l'état solide de cabazitaxel et procédés pour les préparer
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
UA116889C2 (uk) Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc)
PH12016500054A1 (en) Substituted pyrazolo-pyridinamines
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12016500414A1 (en) Solid preparation containing choline alfoscerate and method for preparing same
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
MX2015004314A (es) Formulacion de aroma y fragancia (iii).
WO2016195194A3 (fr) Nouveaux antagonistes de tlr2
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
IN2013MU02584A (fr)
EA201500446A1 (ru) Фармацевтическая композиция для снижения уровня n-оксида триметиламина
TN2013000442A1 (en) FORMULATION FOR ANTI-α4β7 ANTIBODY